The purpose of this study is to learn if training using a walking robotic device (called a "Lokomat") and/or a new oral medication (called "Tizanidine", approved be the FDA) are effective in reducing stiffness in your muscles (called muscle "tone") and in providing functional improvements in your walking capacity.
- Incomplete Spinal Cord Injury
- Level of the SCI lesion between C1-T10
- Spasticity in the lower extremities (increased muscle tone/stiffness)
- Ability to ambulate overground with assistive devices as needed (at least few steps)
Compensation Provided Participants will receive $40 for each testing session. In addition, if participants are assigned for Lokomat training, an additional $15 for each training session attended will be received.
